Literature DB >> 7859355

Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation.

L Baricault1, G Denariaz, J J Houri, C Bouley, C Sapin, G Trugnan.   

Abstract

Epidemiological and in vivo and in vitro experimental studies have suggested that fermented milks may interfere with the emergence and/or the development of colon cancer. The results, however, remain inconclusive. This prompted us to develop a new approach based on the use of HT-29, a cultured human colon cancer cell line, to study at the cellular level the effect of fermented milks on colon cancer cell growth and differentiation characteristics. Undifferentiated HT-29 cells have been grown in the continuous presence of milks fermented by one of the following bacterial populations: Lactobacillus helveticus, Bifidobacterium, L.acidophilus or a mix of Streptococcus thermophilus and L. bulgaricus. Penicillin G was added to the cell culture medium, resulting in a complete blockade of bacterial growth without significant effect on bacterial viability. One out of the four bacteria species studied, namely L.acidophilus, was without effect on both cell growth and differentiation. The three other bacterial strains induced a significant, although variable, reduction in the growth rate of HT-29 cells, which resulted in a 10-50% decrease in the cell number at steady-state (i.e. at cell confluency). The most efficient strains in lowering the HT-29 growth rate were L. helveticus and Bifidobacterium. Concomitantly, the specific activities of dipeptidyl peptidase IV (DPP IV), a sensitive and specific marker of HT-29 cell differentiation, and that of three other brush border enzymes (sucrase, aminopeptidase N and alkaline phosphatase) were significantly increased, thus suggesting that these cells may have entered a differentiation process. Altogether, these results indicate that the use of cultured colon cancer cells may be a useful tool to further study the effect of fermented milks on colon cancer and that bacterial strains may exert a different and specific effect on cancer cell growth and differentiation when used in fermented milk products.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7859355     DOI: 10.1093/carcin/16.2.245

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  14 in total

1.  Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria.

Authors:  N Borruel; M Carol; F Casellas; M Antolín; F de Lara; E Espín; J Naval; F Guarner; J R Malagelada
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

2.  Novel perspectives in probiotic treatment: the efficacy and unveiled mechanisms of the physiological functions.

Authors:  Mikihiro Fujiya; Yutaka Kohgo
Journal:  Clin J Gastroenterol       Date:  2010-05-08

Review 3.  Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer.

Authors:  Constantine-Iosif Fotiadis; Christos-Nikolaou Stoidis; Basileios-Georgiou Spyropoulos; Eleftherios-Dimitriou Zografos
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

4.  Inactivation of dipeptidyl peptidase IV attenuates the virulence of Streptococcus suis serotype 2 that causes streptococcal toxic shock syndrome.

Authors:  Junchao Ge; Youjun Feng; Hongfeng Ji; Huimin Zhang; Feng Zheng; Changjun Wang; Zhimin Yin; Xiuzhen Pan; Jiaqi Tang
Journal:  Curr Microbiol       Date:  2009-05-30       Impact factor: 2.188

Review 5.  Intestinal microbiota, probiotics and human gastrointestinal cancers.

Authors:  Antonella Orlando; Francesco Russo
Journal:  J Gastrointest Cancer       Date:  2013-06

Review 6.  Exploring the Role of Gut Microbiome in Colon Cancer.

Authors:  Indranil Chattopadhyay; Ruby Dhar; Karthikeyan Pethusamy; Ashikh Seethy; Tryambak Srivastava; Ramkishor Sah; Jyoti Sharma; Subhradip Karmakar
Journal:  Appl Biochem Biotechnol       Date:  2021-01-25       Impact factor: 2.926

Review 7.  Mechanisms and therapeutic effectiveness of lactobacilli.

Authors:  Alessandro Di Cerbo; Beniamino Palmieri; Maria Aponte; Julio Cesar Morales-Medina; Tommaso Iannitti
Journal:  J Clin Pathol       Date:  2015-11-17       Impact factor: 3.411

Review 8.  Potential role of probiotics on colorectal cancer prevention.

Authors:  Mario Uccello; Giulia Malaguarnera; Francesco Basile; Velia D'agata; Michele Malaguarnera; Gaetano Bertino; Marco Vacante; Filippo Drago; Antonio Biondi
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

9.  Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence.

Authors:  Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2008-05-20       Impact factor: 6.208

10.  Iodine-125 induces apoptosis via regulating p53, microvessel density, and vascular endothelial growth factor in colorectal cancer.

Authors:  Zhenhuan Ma; Yong Yang; Guokai Yang; Jia Wan; Guojian Li; Ping Lu; Lingjuan Du
Journal:  World J Surg Oncol       Date:  2014-07-17       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.